Videos

Featured

Broadcast

Prevention & Chronic Conditions

Heart Failure
Breakthrough Mineralocorticoid Receptor Agonists in Cardiovascular Care

Vijay Chopra, Javed Butler, Dinesh Khullar , et al

Watch time: 1h 4m 2s

Nir Uriel

Watch time: 34m 39s (5 videos)
The Future of Heart Failure With Dr Yancy

Clyde W Yancy

Watch time: 9m 15s

Jasper J Brugts

Watch time: 2m 59s (15 videos)
AHA 25: HFpEF as an Adipose Tissue Disorder

Milton Packer

Watch time: 5m 43s
AHA 25 Late-breaking Discussion: Analysis from the SURPASS-CVOT Trial

Harriette Van Spall, Stephen Nicholls

Watch time: 12m 43s
AHA 25: The POLY-HF Trial

Ambarish Pandey

Watch time: 4m 15s
ESC 25 Hot Line Discussion: VICTOR: Vericiguat in Heart Failure

Harriette Van Spall, Faiez Zannad

Watch time: 13m 4s
ESC HF 25: The VELOCITY Study

Stephen J Greene

Watch time: 5m 30s
ESC 25: The REBOOT-CNIC Trial

Borja Ibanez

Watch time: 3m 53s
AHA 25: MAPLE-HCM Responder Analysis

Andrew Wang

Watch time: 3m
View from the Thoraxcenter: ESC 21 Late-breaking Science Wrap Up

Joost Daemen, Nicolas M Van Mieghem

Watch time: 36m 1s

Andrew JS Coats, Carolyn Lam

Watch time: 25m 20s (3 videos)
The PRESERVED-HF Study

Mikhail Kosiborod

Watch time: 12m 4s

Broadcast

Anticoagulation

Heart Failure
LAAC Summit Module 1: Reducing stroke risk & bleed in AF patients

A John Camm, Martin Bergmann, Tim Betts

Broadcast

Heart Failure

Imaging & Diagnostics
LAAC Summit Module 2: Focus on imaging in LAAC

Ignacio Cruz, Xavier Iriart, Megan Coylewright , et al

Broadcast

Heart Failure

Imaging & Diagnostics
LAAC Summit Module 3: Addressing complexities in LAAC

Marek Grygier, Jens-Erik Nielsen-Kudsk, Adel Aminian , et al

Mikhail Kosiborod, Dalane W Kitzman

Watch time: 36m 12s (5 videos)

Antoni Bayés-Genís, Julio Núñez

Watch time: 27m 19s (3 videos)

Gerd Hasenfuß, Michael Böhm, Stefan Anker

Watch time: 26m 50s (4 videos)

John JV McMurray, Stefan Anker, , et al

Watch time: 1h 31m 11s (8 videos)
MANAGE-HF: Remote Data May Help Reduce Adverse Events

Larry A Allen

Watch time: 8m 35s
Redwood-HCM: Second-Generation Drug for HCM Well-Tolerated by Patients

Martin S Maron

Watch time: 7m 16s
GALACTIC-HF Subgroup Analysis: Omecamtiv Mecarbil Effective Across Ethnic Groups

David Lanfear

Watch time: 5m 27s
APSC Journal Club - Role of SGLT2i in HFpEF and Its Impact on Renal Outcomes

Jack Tan Wei Chieh, Jonathan Jiunn Liang Yap, James Xu , et al

Watch time: 1h 3m 53s

Perry Elliott

Watch time: 21m 16s (3 videos)

Andrew JS Coats, Shelley Zieroth, Javed Butler, et al